CNBC’s Jim Cramer warned Tuesday that President Donald Trump is creating a “nightmare of potential litigation” for consumer health giant Kenvue Inc. (NYSE:KVUE), sending the company's stock tumbling.

Check out KVUE’s stock price here.

Trump Anticipates Negative Impact Of KVUE’s Medicine On Pregnant Women

Cramer’s comments highlight intense investor fears after reports emerged that the administration is set to publicize a potential link between the use of Tylenol during pregnancy and an increased risk of autism. Shares of Kenvue, the maker of Tylenol, plunged nearly 8%.

The market sell-off followed a report from The Washington Post indicating that administration health officials plan to raise formal concerns about acetaminophen, the active ingredient in Tylenol.

President Trump is expected to publicly discuss data suggesting that pregnant women who take the popular pain reliever increase the risk of their children developing autism.

On the social media platform X, Cramer stated, “Kenvue with a plaintiffs’ problem the likes of which i do not envy. A sitting president creates a nightmare of potential litigation over Tylenol."